Dr. Vishakha Vinay Nakhate, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1318 S. Main Road, Building 1, Vineland, NJ 08360 Phone: 856-691-8585 Fax: 856-692-8489 |
Patti Jo Jaiyeola, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2950 College Dr, Suite 2b, Vineland, NJ 08360 Phone: 856-309-8508 Fax: 856-309-2714 |
Matthew A Fisher, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1318 S Main Road, Vineland, NJ 08360 Phone: 856-691-8585 Fax: 856-691-8489 |
Sara Adel Khalil, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-641-8000 |
Asha J Gandhi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Vineland Developmental Center, 1676 E. Landis Avenue, Vineland, NJ 08382 Phone: 856-696-6431 Fax: 856-794-5803 |
Arnold James Solof, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1138 E Chestnut Ave, #5b, Vineland, NJ 08360 Phone: 856-692-1108 Fax: 856-692-2077 |
Vicky Fiedler, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1505 West Sherman Avenue, Inspira Medical Center Vineland, Vineland, NJ 08060 Phone: 856-651-4945 |
Raghava Shree Kavalla, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-845-0100 |
Dr. Cynthia A Dembofsky, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1505 W Sherman Ave, Vineland, NJ 08360 Phone: 856-845-0100 |
Sonia Y Burgher, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2950 College Drive, Unit 2 C, Vineland, NJ 08360 Phone: 856-692-6000 Fax: 856-692-0609 |
News Archive
A gene that can cause the heart to become enlarged, greatly increasing the risk of heart attacks and heart failure, is identified today in a new study.
Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.
Infinity Pharmaceuticals, Inc. today announced the extension of its global strategic alliance with Mundipharma International Corporation Limited to develop and commercialize IPI-926, Infinity's novel Smoothened antagonist, as well as development candidates arising from Infinity's phosphoinositol-3-kinase (PI3K) and discovery programs.
As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, switching genes on and off. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, can now see - and predict - exactly when each remote control is itself activated, in a real embryo.
› Verified 7 days ago